Long-term continuous ambulatory peritoneal dialysis reduces the expression of CD11B, CD14, CD16, and CD64 on peritoneal macrophages

Peritoneal Dialysis International

Volumn 16, Issue 6, 1996, Pages 582-589

  Cárcamo, Cristina ^a   Fernández Castro, Mercedes ^a,b   Selgas, Rafael ^a   Jiménez, Carlos ^a   Molina, Susana ^a   Vara, Francisco ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Membrane receptors; Nocturnal peritoneal effluent; Peritoneal macrophages

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; FC RECEPTOR; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; AGED; ARTICLE; ASCITES FLUID; CELL SEPARATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CYTOLOGY; FEMALE; HUMAN; IMMUNOLOGY; MACROPHAGE; MALE; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD14; ANTIGENS, CD18; ASCITIC FLUID; CELL SEPARATION; FEMALE; HLA-DR ANTIGENS; HUMANS; INTEGRIN ALPHAXBETA2; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RECEPTORS, IGG;

EID: 0030278242     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD. Analysis of peritoneal macrophages in continuous ambulatory dialysis patients. Kidney Int 1984; 26:733-40.
2. Fernández de Castro M, Selgas R, Jiménez C, et al. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis. Perit Dial Int 1994; 14:265-70.
3. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-34.
4. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-14.
5. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-101.
6. Holmes CJ. Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int 1994; 46(Suppl 48):S58-70.
7. Suassuna JHR, Das Neves FC, Hartley RB, Ogg CS, Cameron JS. Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 1994; 46:443-54.
8. de Haas M, Huizinga TWJ, van der Winkel JGJ, Roos D, von dem Borne AEGKR. Fcγ receptors of myeloid cells. In: Horton MA, ed. Blood cell biochemistry, vol 5: macrophages and related cells. New York: Plenum Press, 1993:261-77.
9. Brodsky FM, Guagliardi L. The cell biology of antigen processing and presentation.Annu Rev Immunol 1991; 9:707-44.
10. Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin.Proc Natl Acad Sci U S A 1981; 78:3039-43.
11. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147:1567-74.
12. + T lymphocytes and monocytes. J Immunol 1987; 138:3817-23.
13. Martin CF, Correale J, Kam-Hansen S, Ehrnst A. Cell cycle-dependent expression of CD4 antigen in a monocytoid cell line. Scand J Immunol 1991; 34:483-9.
14. Cox GW, Mathieson BJ, Giardina SL, Varesio L. Characterization of IL-2 receptor expression and function on murine macrophages. J Immunol 1990; 145:1719-926.
15. de Maria R, Cifone MG, Trotta R, et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180:1999-2004.
16. Lewis DE. Cytochemistry I: cell surface immunofluorescence. In: Bauer KD, Duque RE, Shankey TV, eds. Clinical flow cytometry. Baltimore: Williams & Wilkins, 1993:143-56.
17. Betjes MGH, Tuk CW, Struijk DG, et al. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993; 43:641-8.
18. McGregor SJ, Brock JH, Briggs JD, Junor BJR. Bactericidal activity of peritoneal macrophages from continuous dialysis patients. Nephrol Dial Transplant 1987; 2:104-8.
19. Lin CY, Ku WL, Huang TP. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am J Nephrol 1990; 10:368-73.
20. Lamperi S, Carrozzi S. Defective opsonic activity of peritoneal effluent during CAPD: importance and prevention. Perit Dial Bull 1986; 6:87-92.
21. de Fijter CWH, Verbrugh HA, Oe PL, et al. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992; 42:947-50.
22. Davies SJ, Suassuna J, Ogg CS, Cameron JS.: Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.Kidney Int 1989; 36:661-8.
23. Dasgupta MK, Larabie M, Halloran PF. Interferongamma levels in peritoneal dialysis effluents: relation to peritonitis. Kidney Int 1994; 46:475-81.
24. Macedo A, Orfao A, Ciudad J, San Miguel JF. Phenotypic characterization of normal myeloid differentiation. Sangre 1994; 39:277-82.
25. Griffin JD, Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68:1185-95.
26. Eischen A, Vincent F, Louis B, et al. Immunophenotypic characterisation of human peritoneal and alveolar macrophages and of human blood monocytes differentiated in the presence of either GM-CSF or M-CSF or a combination of GM-CSF/M-CSF. Nouv Rev Fr Hematol 1992; 34:421-34.
27. Eischen A, Duclos B, Schmitt-Goguel M, et al. Human resident peritoneal macrophages: phenotype and biology. Br J HaeMatol 1994; 88:712-22.
28. Mottolese M, Natali PG, Atlante G, Cavallari A, DiFilippo F, Ferrone S. Antigenic profile and functional characterization of human peritoneal macrophages. J Immunol 1985; 135:200-6.
29. Holmes CJ, Lewis SL, Kubey WY, van Epps DE. Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis.Am J Kidney Dis 1990; 15:258-64.
30. Lewis SL, Norris PJ, Holmes CJ. Phenotypic characterization of monocytes and macrophages from CAPD patients. ASAIO Trans 1990; 36:M575-7.
31. Beekhuizen H, Blokland I, Corsèl-van Tilburg AJ, Koning F, van Furth R, CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991; 147:3761-7.
32. Beekhuizen H, Blokland I, van Furth R. Cross-linking of CD14 molecules on monocytes results in a CD11/CD18 and ICAM-1-dependent adherence to cytokine-stimulated human endothelial cells. J Immunol 1993; 150:950-9.
33. Haskill S, Johnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 1988; 140:1690-4.
34. Rosen H, Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med 1987; 166:1685-701.
35. Anderson DC, Schmalsteig FC, Finegold MJ, et al. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis 1985; 152:668-89.
36. Schlesinger LS, Horwitz MA. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest 1990; 85:1304-14.